AVANOS MEDICAL INC (AVNS) Stock Fundamental Analysis

NYSE:AVNS • US05350V1061

14.1 USD
-0.39 (-2.69%)
At close: Feb 27, 2026
14.1 USD
0 (0%)
After Hours: 2/27/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to AVNS. AVNS was compared to 185 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of AVNS get a neutral evaluation. Nothing too spectacular is happening here. AVNS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • AVNS had positive earnings in the past year.
  • AVNS had a positive operating cash flow in the past year.
  • In multiple years AVNS reported negative net income over the last 5 years.
  • AVNS had a positive operating cash flow in each of the past 5 years.
AVNS Yearly Net Income VS EBIT VS OCF VS FCFAVNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M -300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -43.92%, AVNS is doing worse than 64.32% of the companies in the same industry.
  • With a Return On Equity value of -60.27%, AVNS perfoms like the industry average, outperforming 46.49% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 2.68%, AVNS is doing good in the industry, outperforming 68.65% of the companies in the same industry.
  • AVNS had an Average Return On Invested Capital over the past 3 years of 2.58%. This is significantly below the industry average of 8.75%.
  • The 3 year average ROIC (2.58%) for AVNS is below the current ROIC(2.68%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -43.92%
ROE -60.27%
ROIC 2.68%
ROA(3y)-11.6%
ROA(5y)-7.22%
ROE(3y)-16.14%
ROE(5y)-10.03%
ROIC(3y)2.58%
ROIC(5y)N/A
AVNS Yearly ROA, ROE, ROICAVNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30 -40

1.3 Margins

  • The Operating Margin of AVNS (4.46%) is better than 68.65% of its industry peers.
  • AVNS's Operating Margin has improved in the last couple of years.
  • AVNS has a Gross Margin of 52.28%. This is comparable to the rest of the industry: AVNS outperforms 48.11% of its industry peers.
  • AVNS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.46%
PM (TTM) N/A
GM 52.28%
OM growth 3Y42.57%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.25%
GM growth 5Y-0.78%
AVNS Yearly Profit, Operating, Gross MarginsAVNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • AVNS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, AVNS has more shares outstanding
  • AVNS has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, AVNS has an improved debt to assets ratio.
AVNS Yearly Shares OutstandingAVNS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
AVNS Yearly Total Debt VS Total AssetsAVNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • AVNS has an Altman-Z score of 1.35. This is a bad value and indicates that AVNS is not financially healthy and even has some risk of bankruptcy.
  • AVNS has a Altman-Z score (1.35) which is in line with its industry peers.
  • The Debt to FCF ratio of AVNS is 1.38, which is an excellent value as it means it would take AVNS, only 1.38 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of AVNS (1.38) is better than 89.19% of its industry peers.
  • AVNS has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.12, AVNS is in the better half of the industry, outperforming 63.78% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 1.38
Altman-Z 1.35
ROIC/WACC0.27
WACC10.03%
AVNS Yearly LT Debt VS Equity VS FCFAVNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 2.38 indicates that AVNS has no problem at all paying its short term obligations.
  • AVNS has a Current ratio of 2.38. This is comparable to the rest of the industry: AVNS outperforms 45.41% of its industry peers.
  • AVNS has a Quick Ratio of 1.36. This is a normal value and indicates that AVNS is financially healthy and should not expect problems in meeting its short term obligations.
  • AVNS has a Quick ratio of 1.36. This is in the lower half of the industry: AVNS underperforms 61.62% of its industry peers.
Industry RankSector Rank
Current Ratio 2.38
Quick Ratio 1.36
AVNS Yearly Current Assets VS Current LiabilitesAVNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • AVNS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -25.40%.
  • The Earnings Per Share has been growing slightly by 3.80% on average over the past years.
EPS 1Y (TTM)-25.4%
EPS 3Y-17.1%
EPS 5Y3.8%
EPS Q2Q%-30.95%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.72%

3.2 Future

  • AVNS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.57% yearly.
  • Based on estimates for the next years, AVNS will show a small growth in Revenue. The Revenue will grow by 3.19% on average per year.
EPS Next Y3.09%
EPS Next 2Y24.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.16%
Revenue Next 2Y3.19%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AVNS Yearly Revenue VS EstimatesAVNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
AVNS Yearly EPS VS EstimatesAVNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • AVNS is valuated correctly with a Price/Earnings ratio of 15.00.
  • 88.65% of the companies in the same industry are more expensive than AVNS, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.10. AVNS is valued slightly cheaper when compared to this.
  • The Price/Forward Earnings ratio is 14.55, which indicates a correct valuation of AVNS.
  • 88.65% of the companies in the same industry are more expensive than AVNS, based on the Price/Forward Earnings ratio.
  • AVNS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 15
Fwd PE 14.55
AVNS Price Earnings VS Forward Price EarningsAVNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AVNS is valued cheaper than 92.43% of the companies in the same industry.
  • AVNS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AVNS is cheaper than 98.92% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.76
EV/EBITDA 9.83
AVNS Per share dataAVNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AVNS does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as AVNS's earnings are expected to grow with 24.57% in the coming years.
PEG (NY)4.86
PEG (5Y)3.95
EPS Next 2Y24.57%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for AVNS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AVANOS MEDICAL INC

NYSE:AVNS (2/27/2026, 8:04:00 PM)

After market: 14.1 0 (0%)

14.1

-0.39 (-2.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-24
Earnings (Next)05-04
Inst Owners96.89%
Inst Owner Change27.63%
Ins Owners2.95%
Ins Owner Change-0.82%
Market Cap654.52M
Revenue(TTM)N/A
Net Income(TTM)-468.90M
Analysts43.33
Price TargetN/A
Short Float %7.65%
Short Ratio6.09
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)45.42%
Min EPS beat(2)11.11%
Max EPS beat(2)79.74%
EPS beat(4)4
Avg EPS beat(4)33.85%
Min EPS beat(4)2.94%
Max EPS beat(4)79.74%
EPS beat(8)4
Avg EPS beat(8)13.31%
EPS beat(12)7
Avg EPS beat(12)15.99%
EPS beat(16)10
Avg EPS beat(16)13.31%
Revenue beat(2)2
Avg Revenue beat(2)4.82%
Min Revenue beat(2)3.67%
Max Revenue beat(2)5.97%
Revenue beat(4)3
Avg Revenue beat(4)2.62%
Min Revenue beat(4)-0.66%
Max Revenue beat(4)5.97%
Revenue beat(8)3
Avg Revenue beat(8)0.51%
Revenue beat(12)3
Avg Revenue beat(12)-1.11%
Revenue beat(16)3
Avg Revenue beat(16)-4.54%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)13.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.81%
Valuation
Industry RankSector Rank
PE 15
Fwd PE 14.55
P/S 0.94
P/FCF 8.76
P/OCF 6.28
P/B 0.84
P/tB 2.5
EV/EBITDA 9.83
EPS(TTM)0.94
EY6.67%
EPS(NY)0.97
Fwd EY6.87%
FCF(TTM)1.61
FCFY11.41%
OCF(TTM)2.24
OCFY15.92%
SpS15.08
BVpS16.76
TBVpS5.64
PEG (NY)4.86
PEG (5Y)3.95
Graham Number18.83
Profitability
Industry RankSector Rank
ROA -43.92%
ROE -60.27%
ROCE 3.39%
ROIC 2.68%
ROICexc 2.9%
ROICexgc 7.4%
OM 4.46%
PM (TTM) N/A
GM 52.28%
FCFM 10.67%
ROA(3y)-11.6%
ROA(5y)-7.22%
ROE(3y)-16.14%
ROE(5y)-10.03%
ROIC(3y)2.58%
ROIC(5y)N/A
ROICexc(3y)2.84%
ROICexc(5y)N/A
ROICexgc(3y)9.32%
ROICexgc(5y)N/A
ROCE(3y)3.26%
ROCE(5y)N/A
ROICexgc growth 3Y51.11%
ROICexgc growth 5YN/A
ROICexc growth 3Y59.93%
ROICexc growth 5YN/A
OM growth 3Y42.57%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.25%
GM growth 5Y-0.78%
F-Score6
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 1.38
Debt/EBITDA 1.3
Cap/Depr 72.84%
Cap/Sales 4.21%
Interest Coverage 250
Cash Conversion 145.33%
Profit Quality N/A
Current Ratio 2.38
Quick Ratio 1.36
Altman-Z 1.35
F-Score6
WACC10.03%
ROIC/WACC0.27
Cap/Depr(3y)39.4%
Cap/Depr(5y)44.02%
Cap/Sales(3y)2.53%
Cap/Sales(5y)2.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-25.4%
EPS 3Y-17.1%
EPS 5Y3.8%
EPS Q2Q%-30.95%
EPS Next Y3.09%
EPS Next 2Y24.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.72%
Revenue Next Year2.16%
Revenue Next 2Y3.19%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-18.96%
EBIT growth 3Y38.85%
EBIT growth 5YN/A
EBIT Next Year51.47%
EBIT Next 3Y22.03%
EBIT Next 5YN/A
FCF growth 1Y104.1%
FCF growth 3Y7.73%
FCF growth 5YN/A
OCF growth 1Y95.13%
OCF growth 3Y4.87%
OCF growth 5YN/A

AVANOS MEDICAL INC / AVNS FAQ

Can you provide the ChartMill fundamental rating for AVANOS MEDICAL INC?

ChartMill assigns a fundamental rating of 4 / 10 to AVNS.


What is the valuation status for AVNS stock?

ChartMill assigns a valuation rating of 6 / 10 to AVANOS MEDICAL INC (AVNS). This can be considered as Fairly Valued.


Can you provide the profitability details for AVANOS MEDICAL INC?

AVANOS MEDICAL INC (AVNS) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for AVNS stock?

The Earnings per Share (EPS) of AVANOS MEDICAL INC (AVNS) is expected to grow by 3.09% in the next year.